Trending...
- UIFCA Revolutionizes Financial Education with Elite Team of Investment Experts
- Introducing LĪNA Universal Balm: A Luxury Multi-Use, Plant-Powered Solution for Skin & Hair
- PRIMER: An Avant-Garde Art & Music Experience Launches in Chicago's River North Design District
CHICAGO, Sept. 30, 2024 ~ Chicago, IL - Waud Capital Partners, a private equity firm specializing in the software & technology and healthcare sectors, has announced its acquisition of Science Exchange. The leading provider of life sciences procurement and supplier management SaaS solutions marks a significant milestone in its journey with this partnership.
After conducting a thorough evaluation of the life sciences procurement technology market, Waud Capital identified Science Exchange as a standout leader. The company's innovative cloud supplier orchestration platform, delivered through a transparent SaaS subscription model, has gained traction among top global pharmaceutical companies and biotech organizations. Its platform digitizes procurement workflows and drives cost savings, streamlines supplier collaboration, and accelerates project execution.
"We are thrilled to have Waud Capital's support as we solidify our position as the premier SaaS supplier orchestration platform in the life sciences industry," said Elizabeth Iorns, Ph.D., CEO & Co-Founder of Science Exchange. "This partnership will enable us to accelerate our product innovation, drive even faster growth, and expand our impact across the industry."
More on illi News
Waud Capital's proven track record in scaling technology companies and deep experience in healthcare and life sciences make them an ideal partner for Science Exchange's next phase of evolution. "This acquisition is a testament to the strength of Science Exchange's technology and leadership team," said Matthew Clary, Partner at Waud Capital.
Under Waud Capital's ownership, Science Exchange plans to expand its product portfolio, invest in innovative technologies, and elevate its market presence. Elizabeth Iorns will continue as CEO & Co-Founder alongside COO & Co-Founder Dan Knox and Chief Revenue Officer Tzlil Hadass.
Mark Layden will join the company as Executive Chairman under Waud Capital's ownership. "I am incredibly excited to join Science Exchange at this pivotal moment in its growth journey," said Mark Layden. "With Waud's backing and the strength of this talented leadership team, I am confident that Science Exchange will continue to set the standard for supplier orchestration."
Houlihan Lokey acted as financial advisor and Kirkland & Ellis LLP acted as legal counsel to Waud Capital. Union Square Advisors acted as financial advisor and Fenwick & West LLP acted as legal counsel to Science Exchange. The terms of the transaction were not disclosed.
After conducting a thorough evaluation of the life sciences procurement technology market, Waud Capital identified Science Exchange as a standout leader. The company's innovative cloud supplier orchestration platform, delivered through a transparent SaaS subscription model, has gained traction among top global pharmaceutical companies and biotech organizations. Its platform digitizes procurement workflows and drives cost savings, streamlines supplier collaboration, and accelerates project execution.
"We are thrilled to have Waud Capital's support as we solidify our position as the premier SaaS supplier orchestration platform in the life sciences industry," said Elizabeth Iorns, Ph.D., CEO & Co-Founder of Science Exchange. "This partnership will enable us to accelerate our product innovation, drive even faster growth, and expand our impact across the industry."
More on illi News
- Fairmint Introduces First Fully Onchain and Open Cap Table Infrastructure
- Vortex Brands Begins Gold Purchases Under New Joint Venture with Dubai-Based Partner
- Chicago: Mayor Brandon Johnson Statement on the Election of Pope Leo XIV
- City of Naperville Fleet Services Division Ranks No. 7 in the NAFA 100 Best Fleets Competition
- This Budget Didn't Break the System—It Exposed the Truth
Waud Capital's proven track record in scaling technology companies and deep experience in healthcare and life sciences make them an ideal partner for Science Exchange's next phase of evolution. "This acquisition is a testament to the strength of Science Exchange's technology and leadership team," said Matthew Clary, Partner at Waud Capital.
Under Waud Capital's ownership, Science Exchange plans to expand its product portfolio, invest in innovative technologies, and elevate its market presence. Elizabeth Iorns will continue as CEO & Co-Founder alongside COO & Co-Founder Dan Knox and Chief Revenue Officer Tzlil Hadass.
Mark Layden will join the company as Executive Chairman under Waud Capital's ownership. "I am incredibly excited to join Science Exchange at this pivotal moment in its growth journey," said Mark Layden. "With Waud's backing and the strength of this talented leadership team, I am confident that Science Exchange will continue to set the standard for supplier orchestration."
Houlihan Lokey acted as financial advisor and Kirkland & Ellis LLP acted as legal counsel to Waud Capital. Union Square Advisors acted as financial advisor and Fenwick & West LLP acted as legal counsel to Science Exchange. The terms of the transaction were not disclosed.
Filed Under: Business
0 Comments
Latest on illi News
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Beyond Finance Wins Gold Stevie® Award for Customer Service Department of the Year in 23rd Annual American Business Awards
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Mai Coffee Unveils First - Ever Vietnamese Coffee Pouches, Bringing "Viet Super Coffee" To The World
- Chris The Wiz Releases RAIN EP – A Cyberpunk Dreamscape in 4 Tracks
- Penetrium™ Breaks Oncology Barriers: The Solution to Cold Tumors and Metastatic Cancer Unveiled at AACR 2025
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Mayor Brandon Johnson Appoints Francisco Velez as Executive Director of the Chicago Office of Emergency Management and Communications
- Chicago City Council Passes Mayor Johnson's Landmark Green Social Housing Ordinance
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- Transfer Pricing Expert Andrew O'Brien-Penney Joins The Brattle Group as Principal
- Naperville Fire Department Invites Community Members to Fire Prevention Presentation on May 22
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
- Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
- DR Instruments Inc Expands Lab Apparel Line with New 100% Cotton Lab Coats for Adults and Youth
- Visa Named Title Sponsor of Ascending Athletes' Business Owners Summits for NFL Entrepreneurs
- The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
- Powerhouse Dynamics to Showcase Groundbreaking OilSmart by Open Kitchen® Solution at National Restaurant Association Show
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD